CBS 2019
CBSMD教育中心
中 文

充血性心力衰竭

Abstract

Recommended Article

Atrial Fibrillation and the Prognostic Performance of Biomarkers in Heart Failure Two-Year Outcomes with a Magnetically Levitated Cardiac Pump in Heart Failure Impact of Myocardial Scar on Prognostic Implication of Secondary Mitral Regurgitation in Heart Failure Dilated cardiomyopathy: so many cardiomyopathies! Modifiable lifestyle factors and heart failure: A Mendelian randomization study Cardiac resynchronization therapy with a defibrillator (CRTd) in failing heart patients with type 2 diabetes mellitus and treated by glucagon-like peptide 1 receptor agonists (GLP-1 RA) therapy vs. conventional hypoglycemic drugs: arrhythmic burden, hospitalizations for heart failure, and CRTd responders rate Titration of Medical Therapy for Heart Failure With Reduced Ejection Fraction Sex- and Race-Related Differences in Characteristics and Outcomes of Hospitalizations for Heart Failure With Preserved Ejection Fraction

Original Research2020 Dec 10;S1936-878X(20)31001-9.

JOURNAL:JACC Cardiovasc Imaging. Article Link

Impact of Myocardial Scar on Prognostic Implication of Secondary Mitral Regurgitation in Heart Failure

B Tayal, D Debs, F Nabi et al. Keywords: myocardial scar; cardiovascular magnetic resonance; secondary MR; mitral regurgitation volume; mitral regurgitation fraction; HF; LV

Full Text PDF